
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
SaNOtize has developed and patented (issued) a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Target indications include treatment for strep throat, athletes foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu and others. With antibiotic resistance increasing in the world, SaNOtizes platform technology can help fight resistance and bring a new innovating solution to fight infections
Sanotize research and development corp operates in the Biotechnology research industry.
Sanotize research and development corp's revenue is 1m - 10m
Sanotize research and development corp has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.